Carriers of the minor PNPLA3 allele are known to be at risk of the entire spectrum of progressive liver steatosis from NAFLD to NASH, fibrosis, cirrhosis, and hepatocellular carcinoma [26]. This evidence concerns the gene PNPLA3 and metabolic dysfunction-associated steatohepatitis.